Literature DB >> 19917675

kappa-Opioid receptors control the metabolic response to a high-energy diet in mice.

Traci A Czyzyk1, Ruben Nogueiras, John F Lockwood, Jamie H McKinzie, Tamer Coskun, John E Pintar, Craig Hammond, Matthias H Tschöp, Michael A Statnick.   

Abstract

General opioid receptor antagonists reduce food intake and body weight in rodents, but the contributions of specific receptor subtypes are unknown. We examined whether genetic deletion of the kappa-opioid receptor (KOR) in mice alters metabolic physiology. KOR-knockout (KO) and wild-type (WT) mice were fed a high-energy diet (HED) for 16 wk. KO mice had 28% lower body weight and 45% lower fat mass when compared to WT mice fed an HED. No differences in caloric intake were found. An HED reduced energy expenditure in WT mice, but not in KO mice. KOR deficiency led to an attenuation of triglyceride synthesis in the liver. Malonyl CoA levels were also reduced in response to an HED, thereby promoting hepatic beta-oxidation. Glycemic control was also found to be improved in KO mice. These data suggest a key role for KORs in the central nervous system regulation of the metabolic adaptation to an HED, as we were unable to detect expression of KOR in liver, white adipose tissue, or skeletal muscle in WT mice. This study provides the first evidence that KORs play an essential physiological role in the control of hepatic lipid metabolism, and KOR activation is a permissive signal toward fat storage.-Czyzyk, T. A., Nogueiras, R., Lockwood, J. F., McKinzie, J. H., Coskun, T., Pintar, J. E., Hammond, C., Tschöp, M. H., Statnick, M. A. kappa-Opioid receptors control the metabolic response to a high-energy diet in mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19917675      PMCID: PMC2845433          DOI: 10.1096/fj.09-143610

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  44 in total

1.  Localization of kappa opioid receptors in oxytocin magnocellular neurons in the paraventricular and supraoptic nuclei.

Authors:  M J Smith; P M Wise
Journal:  Brain Res       Date:  2001-04-13       Impact factor: 3.252

2.  The kappa opioid receptor and dynorphin co-localize in vasopressin magnocellular neurosecretory neurons in guinea-pig hypothalamus.

Authors:  S J Shuster; M Riedl; X Li; L Vulchanova; R Elde
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

3.  Kappa-Opioid and NMDA glutamate receptors are differentially targeted within rat medial prefrontal cortex.

Authors:  Adena L Svingos; Eric E O Colago
Journal:  Brain Res       Date:  2002-08-16       Impact factor: 3.252

Review 4.  Pathophysiology of obesity.

Authors:  M E Lean
Journal:  Proc Nutr Soc       Date:  2000-08       Impact factor: 6.297

5.  Orexin (hypocretin) neurons contain dynorphin.

Authors:  T C Chou; C E Lee; J Lu; J K Elmquist; J Hara; J T Willie; C T Beuckmann; R M Chemelli; T Sakurai; M Yanagisawa; C B Saper; T E Scammell
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

Review 6.  Exploring the opioid system by gene knockout.

Authors:  Brigitte L Kieffer; Claire Gavériaux-Ruff
Journal:  Prog Neurobiol       Date:  2002-04       Impact factor: 11.685

7.  Peptides that regulate food intake: antagonism of opioid receptors reduces body fat in obese rats by decreasing food intake and stimulating lipid utilization.

Authors:  Michael A Statnick; Frank C Tinsley; Brian J Eastwood; Todd M Suter; Charles H Mitch; Mark L Heiman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-06       Impact factor: 3.619

Review 8.  Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity.

Authors:  Neil B Ruderman; Asish K Saha; Edward W Kraegen
Journal:  Endocrinology       Date:  2003-09-18       Impact factor: 4.736

9.  Combined blockade of both micro - and kappa-opioid receptors prevents the acute orexigenic action of Agouti-related protein.

Authors:  S Brugman; D J Clegg; S C Woods; R J Seeley
Journal:  Endocrinology       Date:  2002-11       Impact factor: 4.736

10.  Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone.

Authors:  Walter Wittmann; Eduard Schunk; Iris Rosskothen; Stefano Gaburro; Nicolas Singewald; Herbert Herzog; Christoph Schwarzer
Journal:  Neuropsychopharmacology       Date:  2008-09-17       Impact factor: 7.853

View more
  27 in total

1.  Mice lacking δ-opioid receptors resist the development of diet-induced obesity.

Authors:  Traci A Czyzyk; Amparo Romero-Picó; John Pintar; Jaime H McKinzie; Matthias H Tschöp; Michael A Statnick; Ruben Nogueiras
Journal:  FASEB J       Date:  2012-05-16       Impact factor: 5.191

2.  The BTBR Mouse, Sociability, and Reduced Glutamate Release: A Role for Endogenous Dynorphin?

Authors:  Keith Fluegge
Journal:  Neurochem Res       Date:  2017-03-16       Impact factor: 3.996

3.  Hypothalamic κ-opioid receptor modulates the orexigenic effect of ghrelin.

Authors:  Amparo Romero-Picó; Maria J Vázquez; David González-Touceda; Cintia Folgueira; Karolina P Skibicka; Mayte Alvarez-Crespo; Margriet A Van Gestel; Douglas A Velásquez; Christoph Schwarzer; Herbert Herzog; Miguel López; Roger A Adan; Suzanne L Dickson; Carlos Diéguez; Rubén Nogueiras
Journal:  Neuropsychopharmacology       Date:  2013-01-24       Impact factor: 7.853

4.  Effects of postnatal overfeeding and fish oil diet on energy expenditure in rats.

Authors:  Yanyan Dai; Nan Zhou; Fan Yang; Shanshan Zhou; Lijun Sha; Jianping Wang; Xiaonan Li
Journal:  Pediatr Res       Date:  2017-10-04       Impact factor: 3.756

Review 5.  Current research on opioid receptor function.

Authors:  Yuan Feng; Xiaozhou He; Yilin Yang; Dongman Chao; Lawrence H Lazarus; Ying Xia
Journal:  Curr Drug Targets       Date:  2012-02       Impact factor: 3.465

Review 6.  Dynorphins in Development and Disease: Implications for Cardiovascular Disease.

Authors:  Cody Cissom; Jason J Paris; Zia Shariat-Madar
Journal:  Curr Mol Med       Date:  2020       Impact factor: 2.222

7.  Metabolic adaptation to calorie restriction.

Authors:  Carlos Guijas; J Rafael Montenegro-Burke; Rigo Cintron-Colon; Xavier Domingo-Almenara; Manuel Sanchez-Alavez; Carlos A Aguirre; Kokila Shankar; Erica L-W Majumder; Elizabeth Billings; Bruno Conti; Gary Siuzdak
Journal:  Sci Signal       Date:  2020-09-08       Impact factor: 8.192

8.  Course of weight change during naltrexone versus methadone maintenance for opioid-dependent patients.

Authors:  David J Mysels; Suzanne K Vosburg; Ileana Benga; Frances R Levin; Maria A Sullivan
Journal:  J Opioid Manag       Date:  2011 Jan-Feb

9.  Direct inhibition of arcuate proopiomelanocortin neurons: a potential mechanism for the orexigenic actions of dynorphin.

Authors:  Xiaobing Zhang; Anthony N van den Pol
Journal:  J Physiol       Date:  2013-01-14       Impact factor: 5.182

10.  Synthesis and evaluation of 11C-LY2795050 as a κ-opioid receptor antagonist radiotracer for PET imaging.

Authors:  Ming-Qiang Zheng; Nabeel Nabulsi; Su Jin Kim; Giampaolo Tomasi; Shu-Fei Lin; Charles Mitch; Steven Quimby; Vanessa Barth; Karen Rash; John Masters; Antonio Navarro; Eric Seest; Evan D Morris; Richard E Carson; Yiyun Huang
Journal:  J Nucl Med       Date:  2013-01-25       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.